The discovery of the Gly341Arg mutation in the RYR1 gene, accounting for ~10% of Caucasian MHS cases, has important implications for the diagnosis and understanding of heterogeneity in malignant hyperthermia.
Answers are grounded in this paper and cite their sources.
May aid MHS diagnosis in Caucasians; leaves open functional validation and broader clinical utility testing.
Malignant hyperthermia (MH) is a potentially fatal autosomal dominant disorder of skeletal muscle and is triggered in susceptible people by all commonly used inhalational anaesthetics. To date, the ryanodine receptor gene (RYR1) has been shown to be mutated in a small number of malignant hyperthermia susceptible (MHS) cases. To determine if a common RYR1 mutation exists that might account for a significant number of MHS cases, we have investigated the RYR1 gene in unrelated patients for the presence of new mutations by the single-stranded conformation polymorphism method and have identified a novel Gly341Arg mutation which accounts for approximately 10% of Caucasian MHS cases. The implications of this common mutation in MHS diagnosis and heterogeneity studies are discussed.
No takes yet. Share an insight, caveat, or question.
Quane et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: